Peptides

A small-molecule NNMT inhibitor, not a peptide, with metabolic findings chiefly from cells and mice.

AHK-Cu 50mg is a copper tripeptide supplied in a branded pre-filled pen with case, available only following online consultation and clinician approval.

AOD-9604 5mg is supplied in a branded pre-filled pen with case, available only following an online consultation and clinician approval.

ARA-290 (Cibinetide) 10mg is an investigational erythropoietin-derived peptide, considered only after online consultation and clinician approval.

A two-component blend without controlled human evidence that the combination improves recovery or offers added benefit.

A synthetic 15-amino-acid peptide with predominantly rodent evidence and no established clinical benefit for injury recovery.

Cardiogen 20mg is a short peptide bioregulator associated with cardiac tissue research, available only following online consultation and clinician approval.

A dual-secretagogue blend with uncertain formulation and no robust clinical evidence for the marketed combination.

A label commonly used for modified GRF(1–29), distinct from the albumin-binding CJC-1295 studied in published trials.

An albumin-binding GHRH analogue studied in small human trials for hormonal responses, not proven wellness outcomes.

Cortagen 20mg is a short peptide bioregulator associated with brain tissue research, available only following online consultation and clinician approval.

An investigational peptide that some people ask about in relation to ageing biology and sleep rhythms.

A copper-binding tripeptide used in cosmetic formulations, with limited human skin evidence and route-specific uncertainties.

GHRP-2 5mg in a branded pre-filled pen with case, available only following an online consultation and clinician approval.

GLOW Blend combines BPC-157, TB-500 and GHK-Cu in a branded pre-filled pen, available only following online consultation and clinician approval.

A glutathione product for discussion with a clinician, with evidence and suitability varying by route.

A synthetic version of natural GnRH used in specific endocrine settings, not an established general libido or testosterone option.

Hexarelin 2mg is a synthetic growth hormone secretagogue, supplied in a branded pre-filled pen with case only following online consultation and clinician approval.

HGH Fragment 176-191 5mg is available in a branded pre-filled pen with case, subject to online consultation and clinician approval.

Humanin 10mg is a mitochondrial-derived peptide, supplied in a branded pre-filled pen with case, subject to online consultation and clinician approval.

A synthetic ghrelin-receptor agonist with early human pharmacology data, not established body-composition or sleep outcomes.

A short KISS1-derived peptide involved in reproductive hormone signalling, with exploratory human studies rather than established intimacy benefits.

KLOW Blend 80mg combines KPV, BPC-157, TB-500 and GHK-Cu in a branded pre-filled pen, available only following online consultation and clinician approval.

A three-amino-acid fragment of alpha-MSH explored mainly in laboratory and animal models of inflammatory signalling.

A naturally occurring nutrient involved in mitochondrial fatty-acid transport, with benefits dependent on the clinical setting.

Lipo-C with B12 10ml combines five ingredients in a branded pre-filled pen, available only following online consultation and clinician approval.

A human cathelicidin peptide with complex immune effects; topical wound studies do not establish injectable benefit.

A mitochondrial-derived peptide of interest in early metabolic research, with substantial uncertainty about human use.

PE-22-28 10mg is a spadin analogue with predominantly preclinical evidence, available through Welcuren only following online consultation, clinician approval and confirmation of lawful supply.

Pinealon 10mg is a tripeptide bioregulator supplied in a branded pre-filled pen with case, subject to online consultation and clinician approval.

A dietary supplement discussed for mitochondrial biology, while human evidence remains preliminary.

A melanocortin receptor agonist with a narrow US licensed indication for acquired, generalised HSDD in premenopausal women.

An investigational triple-hormone peptide, considered only after a full clinician consultation.

A synthetic GHRH(1–29) analogue with historical US paediatric and diagnostic authorisations, not an established anti-ageing option.

A mitochondria-targeting peptide studied in clinical settings, with potential use dependent on product and clinician assessment.

A thymosin beta-4-associated product whose identity and human evidence must not be assumed from its marketing name.

A GHRH analogue with a specific US indication for excess abdominal fat in adults with HIV-associated lipodystrophy.

Thymalin 10mg is a thymus-derived peptide preparation, supplied in a branded pre-filled pen with case only after online consultation and clinician approval.

A synthetic version of a thymic peptide with country-specific approvals and mixed clinical evidence across settings.

VIP 5mg is a naturally occurring neuropeptide, offered in a branded pre-filled pen with case only following online consultation and clinician approval.